Springer Advances in Microbiology, Infectious Diseases and Public Health: Volume 13: 1214 (Advances in Experimental Medicine and Biology, 1214)

Steven Percival (Steven.Percival@5dhpg.com)The Efficacy Of An Electrolysed Water Formulation On Biofilms Neveen Ahmed AbdelAziz (neveen.abdelaziz@gmail.com)Defining the relationship between phenotypic and genotypic resistance profiles of multi-drug resistant enterobacterial clinical isolate Benedetta Amato (benedetta_am@yahoo.it) Lesions consistent with tuberculosis spondylitis in domestic and wild swine and their potential use as a model for Pott disease in humans Iolanda Francolini (iolanda.francolini@uniroma1.it)Usnic acid: potential role in management of wound infections Andreas Vilcinskas (Andreas.Vilcinskas@agrar.uni-giessen.de)Biological profiling of coleoptericins and coleoptericin-like antimicrobial peptides from the invasive harlequin ladybird Harmonia axyridis Mariagrazia Di Luca (diluca.mariagrazia@gmail.com) Real-time antimicrobial susceptibility assay of planktonic and biofilm bacteria by isothermal microcalorimetry E. Caselli csb@unife.itAn Innovative Strategy for the Effective Reduction of MDR Pathogens from the Nosocomial Environment N. Martins, C. F. Rodrigues ncmartins@med.up.pt; c.fortunae@gmail.comNovel Therapies for Biofilm-Based Candida spp. Infections From the Back Cover This book series focuses on current progress in the broad field of medical microbiology, and covers both basic and applied topics related to the study of microbes, their interactions with human and animals, and emerging issues relevant for public health. Original research and review articles present and discuss multidisciplinary findings and developments on various aspects of microbiology, infectious diseases, and their diagnosis, treatment and prevention. The book series publishes review and original research contributions, short reports as well as guest edited thematic book volumes. All contributions will be published online first and collected in book volumes. There are no publication costs. Advances in Microbiology, Infectious Diseases and Public Health is a subseries of Advances in Experimental Medicine and Biology, which has been publishing significant contributions in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences. 2018 Impact Factor: 2.126.